Pharmaceutical Technology

DECEMBER 5, 2022

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In the US, the world’s largest pharmaceutical market, most states have legalized cannabinoids for medical use.

Regulation 245

Regulation Drugs Development Marketing 245

pharmaphorum

NOVEMBER 24, 2021

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.

Production 57

Production Development Trials 57

Rethinking Clinical Trials

OCTOBER 19, 2022

substance use, depression, anxiety, suicidality). Setting is king when you are making some of these decisions; some settings are more academic and are used to these trials. Others are not used to doing trials. This raises a lot of questions: Whose responsibility is it to monitor those risk factors? pctGR, @Collaboratory1.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Medicine 130